ZYNERBA PHARMACEUTICALS, INC. Deferred Offering Costs
ZYNERBA PHARMACEUTICALS, INC. had Deferred Offering Costs of $216.94 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2023-08-14
- 2023-06-30: Deferred Offering Costs $216.94K.
- 2023-03-31: Deferred Offering Costs $210.16K.
- 2022-12-31: Deferred Offering Costs $155.96K.
- 2022-09-30: Deferred Offering Costs $156.27K.
| Period end | Deferred Offering Costs |
|---|---|
| 2023-06-30 | $216.94K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $210.16K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $155.96K 10-Q · filed 2023-08-14 |
| 2022-09-30 | $156.27K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $216.63K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $42.50K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $137.62K 10-K · filed 2023-03-28 |
| 2020-03-31 | $57.53K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $193.50K 10-K · filed 2021-03-10 |
| 2019-09-30 | $130.39K 10-Q · filed 2019-11-06 |
| 2019-03-31 | $178.66K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $255.75K 10-K · filed 2020-03-10 |
| 2018-09-30 | $195.75K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $288.73K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $225.44K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $240.44K 10-K · filed 2019-03-11 |
| 2017-09-30 | $264.63K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $226.51K 10-Q · filed 2017-08-01 |
| 2015-06-30 | $1.95M 10-Q · filed 2015-08-27 |
| 2014-12-31 | $1.08M 10-K · filed 2016-03-14 |